Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility and Safety of HybridAPC for Gastric Mucosal Ablation in the Management of Patients With Obesity.

NCT05587491 is registered in ClinicalTrials.gov with Erbe Elektromedizin GmbH as lead sponsor.

NCT NCT05587491
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05587491 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility and Safety of HybridAPC for Gastric Mucosal Ablation in the Management of Patients With Obesity.
Lead sponsor
Erbe Elektromedizin GmbH
Phase
Not applicable
Overall status
Completed
Start date
February 27, 2023
Completion date
April 15, 2025
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adiposity, obesity